Humabody Logo (WIPO, 12.08.2021)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke Humabody wurde als Bildmarke am 12.08.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Briefe, die eine besondere Form des Schreibens darstellen
| Markenform | Bildmarke |
| Aktenzeichen | 1641475 |
| Länder | 
|
| Basismarke |
Nr. UK00003668766,
14. Juli 2021
|
| Anmeldedatum | 12. August 2021 |
| Ablaufdatum | 12. August 2031 |
Markeninhaber
Meditrina Building,
Babraham Research Campus
GB
Babraham Research Campus
GB
Markenvertreter
15 Clare Road
Halifax HX1 2HY
GB
Waren und Dienstleistungen
01
Chemicals used in industry and science; chemicals for
laboratory research purposes; chemicals for use in medical
research; chemicals for use in oncological research;
antibodies and antibody fragments for scientific and
laboratory use; monoclonal antibodies and antibody fragments
for scientific and laboratory use; antibodies and antibody
fragments for scientific research purposes; antibody
reagents for scientific and laboratory use; antibodies and
antibody fragments for use in medical research; antibodies
and antibody fragments for use in oncological research;
molecules primarily comprised of antibodies and antibody
fragments for use in medical research; molecules primarily
comprised of antibodies and antibody fragments for use in
oncological research; antibodies and antibody fragments for
use in the manufacture of therapeutic products
05
Pharmaceutical and veterinary preparations; therapeutic
preparations for medical and veterinary purposes;
antibodies; antibody fragments; therapeutic preparations
that use monoclonal antibodies; antibodies and antibody
fragments for medical and veterinary diagnostics; antibodies
and antibody fragments for use in the discovery, preclinical
and clinical development of therapeutic products for medical
and veterinary purposes; pharmaceutical preparations in
relation to oncology; antibodies and antibody fragments for
use in oncology and therapeutic treatments in relation
thereto
40
Custom manufacture of chemicals, biologicals, antibodies and
antibody fragments; services for the custom manufacture of
therapies using antibodies and antibody fragments; custom
manufacture of antibody and antibody fragments, for others,
for use in medical therapies, including in relation to
oncology; consultancy, advice and information relating to
all of the aforesaid services
42
Scientific and technological services and research and
design relating thereto; oncological research; laboratory
services relating to antibodies and antibody fragments;
research into the development of antibodies and antibody
fragments; provision of antibodies and antibody fragments
for medical and veterinary research and development;
engineering of antibodies and antibody fragments; scientific
services relating to the discovery, preclinical and clinical
development of therapeutic products; scientific research for
others; research into antibodies, antibody fragments for
others; research into the formation, manufacture, medical
usage and manipulation of antibodies and antibody fragments
for others; consultancy, advice and information relating to
all of the aforesaid services
45
Licensing of research and development; licensing of medical
therapeutic research; licensing of research relating to
antibodies and antibody fragments; licensing of research in
relation to the formation, manufacture, medical usage and
manipulation of antibodies and antibody fragments;
consultancy, advice and information relating to all of the
aforesaid services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 20. Juli 2023 | 2023/31 Gaz | RAW: Holder Rights Restriction | |
| 06. April 2023 | 2023/15 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 20. Dezember 2022 | 2022/51 Gaz | CH | Ablehnung |
| 04. November 2022 | 2022/45 Gaz | CN | Ablehnung |
| 03. November 2022 | 2022/44 Gaz | JP | Ablehnung |
| 22. Juni 2022 | 2022/25 Gaz | EM | Ablehnung |
| 16. Juni 2022 | 2022/25 Gaz | US | Ablehnung |
| 21. April 2022 | 2022/16 Gaz | AU | Ablehnung |
| 12. August 2021 | GB | Eintragung |
ID: 141641475